Discover 731 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 731
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
1 location in Austin
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
1 location in Round Rock
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
for
SARS-CoV-2
1 location in Round Rock
Sponsor: ModernaTX, Inc.
Sex: All
Age: 50 - 64
Code: NCT07266558
Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
1 location in Round Rock
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
1 location in Pflugerville
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
for
Hypertension
1 location in Austin
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06857955
Phase2, Recruiting
Active & ResponsiveNew
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
for
Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic,
1 location in Austin
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07444814
Phase1, Recruiting
Active & ResponsiveNew
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
for
Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer
1 location in Austin
Sponsor: Boundless Bio, Inc.
Sex: All
Age: 18+
Code: NCT07408089
Phase1, Recruiting
Active & Responsive
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
1 location in Austin
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07361562
Phase1, Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,